Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence (2019)

First Author: McCulloch L

Attributed to: Understanding and manipulating innate-like B cell mechanisms to prevent stroke-associated infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/587881

Publication URI: http://dx.doi.org/10.1101/587881

Type: Preprint